Sir. Andrew Witty
Chief Executive Officer
GSK CEO Sir Andrew Witty interviewed on Q4 and full-year 2011 results
GlaxoSmithKline CEO Sir Andrew Witty talks about the drugs giantâ€™s special dividend, solid results and why the company is so well positioned to continue to deliver. He also looks at regional dynamics including performance in emerging markes, Japan and the US, plus pipeline developments and R&D.;
[ close ]
Information and opinions contained in this broadcast have been compiled or arrived at by the organisation making this presentation. Any statements, information and opinions contained in this broadcast,
in particular those concerning investments and the possible or assumed future performance, costs, dividends, returns, production levels or rates, prices, reserves, divestments, growth or other trend
projections and any estimated earnings are or may be forward looking statements and as such involve risks and uncertainties. Actual results and developments may differ materially from those expressed
or implied by these statements depending on a variety of factors.
This broadcast is brought to you by 3B NEXUS who make no representation or warranty regarding the accuracy or reliability or completeness of any information provided and accepts no liability for any
loss arising from the use hereof. Any reliance you place on such information will be at your sole risk.